BROWN MICHAEL S — SEC insider filings
SEC reporting owner CIK 1174475. 23 insider filings on record with FilingPulse; latest filed 2026-11-03.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2020-09-23 to 2026-11-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 49 legs across 17 filings — 47,067 shares, $33,004,268 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 53.
- Largest priced transaction: sale of 5,090 shares @ $552.36 ($2,811,512) in REGENERON PHARMACEUTICALS, INC., filed 2020-09-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. (REGN) | Director | 23 | — | 49 legs · 47,067 sh · $33,004,268 | 53 |
Insider filings — BROWN MICHAEL S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-03 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,929 @ $725.89 · Sale (S): 1,929 @ $875 · Option exercise (M): 1,929 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 155 @ $0 · Grant/award (A): 1,962 (derivative) @ $0 | EDGAR |
| 2025-01-06 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 166 @ $0 · Grant/award (A): 1,958 (derivative) @ $0 | EDGAR |
| 2024-06-17 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,535 @ $625.60 · Sale (S): 1,535 @ $1,040 · Option exercise (M): 1,535 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,172 @ $625.60 · Sale (S): 1,172 @ $974.86 · Option exercise (M): 1,172 (derivative) @ $0 | EDGAR |
| 2024-01-04 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 135 @ $0 · Grant/award (A): 1,607 (derivative) @ $0 | EDGAR |
| 2023-12-29 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 2,049 @ $482.68 · Sale (S): 2,049 @ $898 · Option exercise (M): 2,049 (derivative) @ $0 | EDGAR |
| 2023-04-24 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 3,070 @ $520.01 · Sale (S): 3,070 @ $798.42 · Option exercise (M): 3,070 (derivative) @ $0 | EDGAR |
| 2023-02-08 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 3,071 @ $520.01 · Sale (S): 3,071 @ $798 · Sale (S): 500 @ $797 · Option exercise (M): 3,071 (derivative) @ $0 | EDGAR |
| 2023-01-30 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1 @ $520.01 · Sale (S): 1 @ $747 · Option exercise (M): 1 (derivative) @ $0 | EDGAR |
| 2023-01-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 3,070 @ $520.01 · Sale (S): 3,070 @ $747.14 · Option exercise (M): 3,070 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 165 @ $0 · Grant/award (A): 1,929 (derivative) @ $0 | EDGAR |
| 2022-11-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 2,431 @ $374.12 · Sale (S): 1,764 @ $748.48 · Option exercise (M): 1,564 @ $482.68 · Sale (S): 126 @ $751.23 · Sale (S): 203 @ $752.14 · Sale (S): 300 @ $753.66 · +12 more | EDGAR |
| 2022-03-31 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,522 @ $374.12 · Sale (S): 1,522 @ $699 · Option exercise (M): 408 @ $374.12 · Sale (S): 408 @ $699 · Option exercise (M): 1,522 (derivative) @ $0 · Option exercise (M): 408 (derivative) @ $0 | EDGAR |
| 2022-02-24 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 500 @ $608.68 | EDGAR |
| 2022-01-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 191 @ $0 · Grant/award (A): 2,707 (derivative) @ $0 | EDGAR |
| 2021-09-15 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 2,479 @ $380.95 · Option exercise (M): 3,613 @ $413.33 · Option exercise (M): 3,612 @ $413.33 · Sale (S): 100 @ $636.74 · Sale (S): 200 @ $637.29 · Sale (S): 676 @ $638.64 · +17 more | EDGAR |
| 2021-08-10 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale (S): 1,687 @ $612.38 | EDGAR |
| 2021-06-28 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 2,084 @ $371.40 · Sale (S): 2,084 @ $549 · Option exercise (M): 2,084 (derivative) @ $0 | EDGAR |
| 2021-06-16 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 1,700 @ $371.40 · Sale (S): 1,700 @ $525 · Option exercise (M): 1,700 (derivative) @ $0 | EDGAR |
| 2021-01-27 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 2,480 @ $380.95 · Sale (S): 2,480 @ $554.32 · Option exercise (M): 2,480 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/award (A): 248 @ $0 · Grant/award (A): 3,613 (derivative) @ $0 | EDGAR |
| 2020-09-23 | 4 | REGENERON PHARMACEUTICALS, INC. (REGN) | Option exercise (M): 2,480 @ $380.95 · Option exercise (M): 2,610 @ $376.69 · Sale (S): 5,090 @ $552.36 · Gift (G): 1,000 @ $0 · Sale (S): 1,000 @ $552.36 · Option exercise (M): 2,610 (derivative) @ $0 · +1 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-21 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1174475 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs